a-GLUCOSIDASE INHIBITOR, INVERTASE INHIBITOR, AND SUGAR ABSORPTION INHIBITOR
US-2022409649-A1 · Dec 29, 2022 · US
Pharmaceutical composition comprising maple leaf extract for preventing or treating retinal disease
US11564962B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11564962-B2 |
| Application number | US-201716325958-A |
| Country | US |
| Kind code | B2 |
| Filing date | Aug 11, 2017 |
| Priority date | Aug 16, 2016 |
| Publication date | Jan 31, 2023 |
| Grant date | Jan 31, 2023 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present invention relates to a pharmaceutical composition comprising a maple leaf extract or fraction thereof for preventing or treating a retinal disease, a method for preventing or treating a retinal disease using the pharmaceutical composition, and a food composition comprising a maple leaf extract or fraction thereof for ameliorating the symptoms of a retinal disease.The pharmaceutical composition according to the present invention, which is effective for the treatment of a retinal disease, can be used pharmaceutically as a composition for preventing or treating a retinal disease, and can also be used advantageously as a health functional food.
First claim
Opening claim text (preview).
The invention claimed is: 1. A method for treating a retinal disease, comprising a step of administering a pharmaceutically effective amount of a composition which comprises a maple leaf extract to a subject in need thereof, wherein the retinal disease comprises nerve damage or ischemic damage to the retina or macula thereof or degeneration therefrom, and wherein the retinal disease is at least one disease selected from the group consisting of retinal artery occlusion, retinal vein occlusion, retinal periphlebitis, hypertensive retinopathy, diabetic retinopathy, retinopathy of prematurity, sensory neuroretinal inflammation, inflammation of the retinal pigment epithelium, retinitis pigmentosa, angioid streaks, drusen, rhegmatogenous retinal detachment, non-rhegmatogenous retinal detachment, macular degeneration, macular dystrophy, diabetic retinopathy, retinal arteriovenous occlusion, hypertensive retinopathy, retinal aortic aneurysm, retinal ischemic syndrome, radiation retinopathy, retinopathy of prematurity, acute retinal necrosis, retinitis, retinal choroiditis, retinal detachment, retinal tumor, retinal damage due to trauma, and retinal damage due to light. 2. The method of claim 1 , wherein the pharmaceutical composition reduces the expression of at least one selected from the group consisting of Cleaved PARP, GFAP, and Nestin. 3. The method of claim 1 , wherein the pharmaceutical composition increases the expression of at least one selected from the group consisting of OPNISW, Brn3a, and Tuj-1.
Assignees
Inventors
Classifications
- A61K36/20Primary
Aceraceae (Maple family) · CPC title
Foods, ingredients or supplements having a functional effect on health · CPC title
Ophthalmic agents · CPC title
Plant extracts, their artificial duplicates or their derivatives · CPC title
Plant extracts · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US11564962B2 cover?
- The present invention relates to a pharmaceutical composition comprising a maple leaf extract or fraction thereof for preventing or treating a retinal disease, a method for preventing or treating a retinal disease using the pharmaceutical composition, and a food composition comprising a maple leaf extract or fraction thereof for ameliorating the symptoms of a retinal disease.The pharmaceutical …
- Who is the assignee on this patent?
- Korea Inst Oriental Medicine
- What technology area does this patent fall under?
- Primary CPC classification A61K36/20. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Jan 31 2023 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 5 related publications on this page (citations in our corpus or others sharing the same primary CPC).